Role of Aspirin in Managing Hypertension
Low-dose aspirin (75-100 mg/day) should only be prescribed to hypertensive patients with high cardiovascular risk (≥20% 10-year risk or ≥5% cardiovascular death risk) and well-controlled blood pressure (<150/90 mmHg), as the benefits outweigh bleeding risks only in these specific populations. 1
Risk-Benefit Assessment for Aspirin Use
Aspirin therapy in hypertension requires careful consideration of both cardiovascular benefits and bleeding risks:
Benefits:
- Reduces major cardiovascular events by approximately 15% 1
- Reduces acute myocardial infarction by approximately 36% 1, 2
- No significant effect on stroke incidence 1, 2
Risks:
- Increases major hemorrhagic events by 65% 1, 2
- Approximately doubles the risk of major extracranial bleeding 1
Patient Selection Algorithm for Aspirin Therapy
Recommended for:
- Hypertensive patients <80 years with:
Specific high-benefit subgroups:
- Patients with elevated serum creatinine >115 μmol/l (1.3 mg/dl) 1, 3
- Patients with diabetes mellitus 4, 2
- Patients with higher baseline systolic (≥180 mmHg) or diastolic (≥107 mmHg) blood pressure 1, 3
Not recommended for:
- Patients with low cardiovascular risk where harm may outweigh benefits 1
- Patients with uncontrolled hypertension 1
- Patients with high bleeding risk without compelling cardiovascular indications 1
Dosing and Administration
- Optimal dose: 75-100 mg daily 1
- Timing: No specific recommendation for timing in hypertension management
- Duration: Long-term therapy for eligible patients 1
Important Clinical Considerations
Interaction with Antihypertensive Medications
- Low-dose aspirin does not interfere with blood pressure-lowering effects of antihypertensive medications, including ACE inhibitors 5
- No need to adjust antihypertensive medication doses when adding aspirin 5
Monitoring
- Regular reassessment of cardiovascular risk and bleeding risk 1
- Monitor for signs of gastrointestinal bleeding 1, 2
- Periodically reassess blood pressure control 1
Common Pitfalls to Avoid
- Prescribing aspirin to all hypertensive patients regardless of risk: The benefit-risk ratio is favorable only in high-risk patients 1
- Using aspirin for blood pressure control: Despite some claims, aspirin is not an antihypertensive medication and should not be used for blood pressure lowering 6
- Ignoring bleeding risk factors: Age >70 years, history of GI bleeding, concurrent use of anticoagulants/NSAIDs, and uncontrolled hypertension increase bleeding risk 1, 4
- Failure to ensure adequate blood pressure control: Uncontrolled hypertension may attenuate aspirin's cardiovascular benefits and increase bleeding risk 1
Special Populations
Diabetic Patients with Hypertension
- Aspirin therapy is recommended for diabetic hypertensive patients with established cardiovascular disease 4
- For primary prevention in diabetics, consider aspirin if 10-year CVD risk is >5-10% 4
- Particularly beneficial in diabetic patients with target organ damage 4
Elderly Patients
- Benefits may be greater due to higher baseline cardiovascular risk
- However, bleeding risk also increases with age
- Use with caution in patients >80 years 1
In conclusion, aspirin is not a treatment for hypertension itself but rather an adjunctive therapy for reducing cardiovascular events in selected high-risk hypertensive patients with well-controlled blood pressure.